Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

Entrevistamos Arianna Lint, miembro del Consejo Asesor de la Comunidad y Una Chica Como Yo blogger, para nuestra "Enfoque: Mujeres Creando Diferencia" serie.

Learn about peripheral neuropathy – what it is, what puts people at risk of developing it, its signs and symptoms, and available treatments.

Obtener información acerca de las mujeres trans que viven con el VIH y los muchos problemas únicos que se enfrentan, incluyendo algunas buenas noticias sobre los cambios y la capacidad de recuperación determinado.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>